Genelux's Unattributed - II Round

Genelux raised a round of funding on July 15, 2010.

Genelux is a clinical stage biopharmaceutical company with a mission to change the way in which cancer is diagnosed and treated. The company has developed an oncolytic virus-based technology platform …

Articles about Genelux's Unattributed - II Round: